Adam oversees a global team of Biotechnologists - scientists, engineers, and technicians - dedicated to advancing the company's growth-through-innovation goals. His primary focus is on translating laboratory innovations into successful biomanufacturing outcomes. His team engages in all phases of the innovation lifecycle, from ideation to execution, focusing on developing sensorial, nutritional, and health-related ingredients and application solutions.

Adam is responsible for the formulation of short, medium, and long-term biotechnology product development and commercialization strategies for dsm-firmenich. Utilizing a blend of classical and modern biotechnological methodologies, including engineering biology and precision fermentation, alongside digital technologies, his team strives to create sustainable biosolutions and enhance the performance of existing products.

His team is committed to developing environmentally friendly solutions that reduce waste, lower carbon footprints, and promote resource efficiency. By leveraging cutting-edge technologies and sustainable practices, dsm-firmenich aims to contribute positively to global environmental goals and deliver products that support a healthier planet.